Revelation Biosciences, Inc. (REVB) analyst actions
Rating and price-target actions on REVB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the REVB overview →
1 measured REVB analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development | Press release | +0.00% | +1.14% |
Keep exploring
More REVB: earnings → · SEC filings → · REVB overview →
Other Financial Services names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| First Hawaiian, Inc. (FHB) | 224 | 0.00% | 47% |
| LANCASHIRE HLDGS LTD ORD (LCSHF) | 224 | 0.00% | 0% |
| BTCS Inc. (BTCS) | 222 | -0.38% | 39% |
| ConnectOne Bancorp, Inc. (CNOB) | 222 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.